Cerevel Therapeutics Holdings, Inc.Cerevel Therapeutics Holdings, Inc.Cerevel Therapeutics Holdings, Inc.

Cerevel Therapeutics Holdings, Inc.

No trades
See on Supercharts

Price target

45.000.00 0.00%
The 5 analysts offering 1 year price forecasts for CERE have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to CERE in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

In the next quarter Cerevel Therapeutics Holdings, Inc. revenue is expected to reach 0 USD. Check out Cerevel Therapeutics Holdings, Inc. revenue and earnings and make informed decisions.
According to analysts, CERE price target is 45.00 USD with a max estimate of 45.00 USD and a min estimate of 45.00 USD. Check if this forecast comes true in a year, meanwhile watch Cerevel Therapeutics Holdings, Inc. stock price chart and keep track of the current situation with CERE news and stock market news.
We've gathered opinions of 6 analysts rating CERE stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.